France Personalized Medicine Market Size & Outlook
France personalized medicine market, 2018-2030 (US$M)
Related Markets
France personalized medicine market highlights
- The France personalized medicine market generated a revenue of USD 17,096.0 million in 2023 and is expected to reach USD 29,985.3 million by 2030.
- The France market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
- In terms of segment, personalized nutrition & wellness was the largest revenue generating product in 2023.
- PM Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Personalized medicine market data book summary
| Market revenue in 2023 | USD 17,096.0 million |
| Market revenue in 2030 | USD 29,985.3 million |
| Growth rate | 8.4% (CAGR from 2023 to 2030) |
| Largest segment | Personalized nutrition & wellness |
| Fastest growing segment | PM Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, France accounted for 3.2% of the global personalized medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany personalized medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 54,024.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Medicine Market Scope
Personalized Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France personalized medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 32.28% in 2023. Horizon Databook has segmented the France personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare system in France relies heavily on government funds and national healthcare insurance. In 2015, a French Plan for Genomic Medicine 2025 was licensed. This plan was further developed and streamlined in 2016 by the French National Alliance for Life Sciences and Health (Aviesan).
Furthermore, Human Precision MEDicine (Hu-PreciMED) project was launched by Intersystems & Oncodesign and is aimed at structuring the precision medicine industry in France. It includes over 45 medical and digital companies. Cap Digital and Medicen Paris Region are the prominent players that support advancements in this project.
Reasons to subscribe to France personalized medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France personalized medicine market databook
-
Our clientele includes a mix of personalized medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into France personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France personalized medicine market size, by product, 2018-2030 (US$M)
France Personalized Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
